肺動脈高血圧の世界市場:薬物クラス別(プロスタサイクリン&プロスタサイクリン類似体、ERA、PDE-5)

◆英語タイトル:Pulmonary Arterial Hypertension Market Size, Share & Trends Analysis Report By Drug Class (Prostacyclin & Prostacyclin Analogs, Endothelin Receptor Antagonists, Phosphodiesterase 5), And Segment Forecasts, 2020 - 2027
◆商品コード:GV20MY067
◆発行会社(リサーチ会社):Grand View Research
◆発行日:2020年3月12日
◆ページ数:140
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD5,950 ⇒換算¥642,600見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算¥750,600見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算¥966,600見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGrand View Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Grand View Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査レポートでは、肺動脈高血圧の世界市場について調査・分析し、調査手法・範囲、エグゼクティブサマリー、市場要因・動向・範囲、薬物クラス別(プロスタサイクリン&プロスタサイクリン類似体、ERA、PDE-5)分析、地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東及びアフリカ)分析、企業概要などの構成でお届けいたします。
・調査手法・範囲
・エグゼクティブサマリー
・市場要因・動向・範囲
・肺動脈高血圧の世界市場:薬物クラス別(プロスタサイクリン&プロスタサイクリン類似体、ERA、PDE-5)
・肺動脈高血圧の世界市場:地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東及びアフリカ)
・企業概要
【レポートの概要】

The global pulmonary arterial hypertension market size is expected to reach USD 9.8 billion by 2027, according to a new report by Grand View Research, Inc., registering a CAGR of 5.6% over the forecast period. Increasing prevalence rates of pulmonary arterial hypertension (PAH) and government support for the development of orphan drugs drive the market growth.

The cases of PAH are rising in the range of 100,000 to 200,000 per year. However, in the past few years, the occurrence of PAH has been increasing due to risk factors such as alcohol/tobacco consumption, HIV, sedentary lifestyle, smoking, and other idiopathic conditions. Moreover, the geriatric population is more prone to PAH and associated diseases owing to reduced immune function. According to the National Council on Aging (NCOA), about 80 percent of the population aged 65 and above have at least one chronic condition such as high cholesterol, diabetes, heart or kidney disease, or chronic obstructive pulmonary disease.

Government initiatives such as the Rare Disease Act 2002 and The Orphan Drug Act (ODA) 1983, are also anticipated to support the market for treatment drugs for PAH. These acts play a significant role in promoting the ethical usage and distribution of orphan drugs. The development of orphan drugs is promoted by the National Organization of Rare Disorders.

Robust drug pipeline and new product combinations awaiting approval or launch are anticipated to increase the PAH market competitiveness over the forecast period. In September 2019, Acceleron Pharma, a leading biopharmaceutical company, received FDA orphan drug designation for sotatercept for the treatment of pulmonary arterial hypertension.

Further key findings from the report suggest:

• Prostacyclin and its analogs for treating PAH are projected to show lucrative growth over the forecast period. The sales of these drugs are anticipated to increase due to the growing use of oral prostacyclin agents

• North America dominated the PAH market with a share of over 55.0% in 2019. This is attributed to the well-established infrastructure for the development and distribution of high-quality therapies and the availability of reimbursement for PAH therapies

• Asia Pacific is estimated to register the highest CAGR of more than 6.0% over the forecast period due to its huge population base, rapid economic development, and improving healthcare system. Moreover, the high burden of diseases such as HIV in the region contribute to the development of PAH

• The major players in the pulmonary arterial hypertension market that offer treatment solutions for PAH include GlaxoSmithKline plc; Johnson & Johnson Services, Inc. (Actelion Pharmaceuticals, Ltd.); United Therapeutics Corporation; Pfizer, Inc.; and Gilead Sciences, Inc. The market is consolidated and competitive in nature. The players enjoy the benefit of high entry barriers to other firms due to high price interdependency

【レポートの目次】

Table of Contents

Chapter 1 Methodology and Scope
1.1 Market Segmentation & Scope
1.1.1 Drug
1.1.2 Regional Scope
1.1.3 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Gvr’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information Or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.6.1.1 Approach 1: Commodity Flow Approach
1.6.2 Volume Price Analysis (Model 2)
1.6.2.1 Approach 2: Volume Price Analysis
1.7 List of Secondary Sources
1.8 List of Primary Sources
1.9 List of Abbreviations
1.10 Objectives
1.10.1 Objective – 1:
1.10.2 Objective – 2:
1.10.3 Objective – 3:
1.10.4 Objective – 4:
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.3 Business Segment Trends
2.3.1 Service Business Analysis
2.3.2 Application Business Analysis
2.3.3 Regional Business Analysis
2.4 Competitive Insights
Chapter 3 Pulmonary Arterial Hypertension Market: Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.2 Ancillary Market Outlook
3.2 Penetration & Growth Prospect Mapping
3.3 Product Pipeline Analysis, By Stage
3.3.1 Registration Phase
3.4 User Perspective Analysis
3.4.1 Consumer Behavior Analysis
3.4.2 Market Influencer Analysis
3.5 List Of Key End-Users, By Region / By Product / By Country
3.6 Regulatory Framework
3.6.1 Reimbursement Framework
3.6.1.1 Therapy Cost
3.6.1.2 Therapy Monitoring Cost
3.6.1.3 Average Selling Price
3.6.2 Standards & Compliances
3.7 Market Variable Analysis
3.7.1 Market Driver Analysis
3.7.1.1 Incidents Of Pulmonary Arterial Hypertension (PAH)
3.7.1.2 Growing Geriatric Population
3.7.1.3 Government Support For Development Of Orphan Drugs
3.7.2 Market Restraint Analysis
3.7.2.1 Patent Expiration Of Key Molecules
3.7.3 Industry Challenges
3.8 Pulmonary Arterial Hypertension Market: Analysis Tools
3.8.1 Porter’s Five Forces Analysis
3.8.1.1 Supplier Power: Low
3.8.1.2 Buyer Power: Moderate
3.8.1.3 Substitution Threat: Moderate
3.8.1.4 Threat From New Entrant: Moderate
3.8.1.5 Competitive Rivalry: High
3.8.2 Pestel Analysis
3.8.3 Major Deals & Strategic Alliances Analysis
3.8.4 Market Entry Strategies
Chapter 4 Pulmonary Arterial Hypertension Market: Drug Class Segment Analysis
4.1 Pulmonary Arterial Hypertension Market: Definition & Scope
4.2 Pulmonary Arterial Hypertension: Market Share Analysis, 2019 & 2027
4.3 Prostacyclin and Prostacyclin Analogs
4.3.1 Prostacyclin and Prostacyclin Analogs market, 2016 – 2027 (USD Million)
4.4 Soluble Guanylate Cyclase (SGC) Stimulators
4.4.1 Soluble Guanylate Cyclase (SGC) Stimulators market, 2016 – 2027 (USD Million)
4.5 Endothelin Receptor Antagonists (ERAs)
4.5.1 Endothelin Receptor Antagonists (ERAS) market, 2016 – 2027 (USD Million)
4.6 Phosphodiesterase 5 (PDE-5)
4.6.1 Phosphodiesterase 5 (PDE-5) market, 2016 – 2027 (USD Million)
Chapter 5 Pulmonary Arterial Hypertension Market: Regional Analysis
5.1 Pulmonary Arterial Hypertension Market: Definition & Scope
5.2 Regional Market Snapshot
5.3 Regional Market Share and Leading Players, 2018
5.3.1 North America
5.3.2 Europe
5.3.3 Asia Pacific
5.3.4 Latin America
5.3.5 Middle East & Africa
5.4 Pulmonary Arterial Hypertension Market: Market Share Analysis, 2018 & 2027
5.5 North America
5.5.1 North America Pulmonary Arterial Hypertension market, 2016 – 2027 (USD Million)
5.5.2 U.S.
5.5.2.1 U.S. Pulmonary Arterial Hypertension market, 2016 – 2027 (USD Million)
5.5.3 Canada
5.5.3.1 Canada Pulmonary Arterial Hypertension market, 2016 – 2027 (USD Million)
5.6 Europe
5.6.1 Europe Pulmonary Arterial Hypertension market, 2016 – 2027 (USD Million)
5.6.2 U.K.
5.6.2.1 U.K. Pulmonary Arterial Hypertension market, 2016 – 2027 (USD Million)
5.6.3 Germany
5.6.3.1 Germany Pulmonary Arterial Hypertension market, 2016 – 2027 (USD Million)
5.6.4 France
5.6.4.1 France Pulmonary Arterial Hypertension market, 2016 – 2027 (USD Million)
5.6.5 Italy
5.6.5.1 Italy Pulmonary Arterial Hypertension market, 2016 – 2027 (USD Million)
5.6.6 Spain
5.6.6.1 Spain Pulmonary Arterial Hypertension market, 2016 – 2027 (USD Million)
5.7 Asia Pacific
5.7.1 Asia Pacific Pulmonary Arterial Hypertension market, 2016 – 2027 (USD Million)
5.7.2 Japan
5.7.2.1 Japan Pulmonary Arterial Hypertension market, 2016 – 2027 (USD Million)
5.7.3 China
5.7.3.1 China Pulmonary Arterial Hypertension market, 2016 – 2027 (USD Million)
5.7.4 Australia
5.7.4.1 Australia Pulmonary Arterial Hypertension market, 2016 – 2027 (USD Million)
5.7.5 South Korea
5.7.5.1 South Korea Pulmonary Arterial Hypertension market, 2016 – 2027 (USD Million)
5.7.6 India
5.7.6.1 India Pulmonary Arterial Hypertension market, 2016 – 2027 (USD Million)
5.8 Latin America
5.8.1 Latin America Pulmonary Arterial Hypertension market, 2016 – 2027 (USD Million)
5.8.2 Brazil
5.8.2.1 Brazil Pulmonary Arterial Hypertension market, 2016 – 2027 (USD Million)
5.8.3 Mexico
5.8.3.1 Mexico Pulmonary Arterial Hypertension market, 2016 – 2027 (USD Million)
5.8.4 Argentina
5.8.4.1 Argentina Pulmonary Arterial Hypertension market, 2016 – 2027 (USD Million)
5.9 MEA
5.9.1 MEA Pulmonary Arterial Hypertension market, 2016 – 2027 (USD Million)
5.9.2 South Africa
5.9.2.1 South Africa Pulmonary Arterial Hypertension market, 2016 – 2027 (USD Million)
5.9.3 Saudi Arabia.
5.9.3.1 Saudi Arabia Pulmonary Arterial Hypertension market, 2016 – 2027 (USD Million)
5.9.4 UAE
5.9.4.1 UAE Pulmonary Arterial Hypertension market, 2016 – 2027 (USD Million)
Chapter 6 Company Profiles
6.1 Company Profiles
6.1.1 Johnson & Johnson Services, Inc. (Actelion Pharmaceuticals, Ltd.)
6.1.1.1 Company overview
6.1.1.2 Financial performance
6.1.1.3 Product benchmarking
6.1.1.4 Strategic initiatives
6.1.2 Gilead Sciences, Inc.
6.1.2.1 Company overview
6.1.2.2 Financial Performance
6.1.2.3 Product benchmarking
6.1.2.4 Strategic initiatives
6.1.3 United Therapeutics Corporation
6.1.3.1 Company overview
6.1.3.2 Financial performance
6.1.3.3 PAH Global Sale
6.1.3.4 Product benchmarking
6.1.3.5 Strategic initiatives
6.1.4 Novartis International AG
6.1.4.1 Company overview
6.1.4.2 Financial Performance
6.1.4.3 Product benchmarking
6.1.4.4 Strategic initiatives
6.1.5 GlaxoSmithKline Plc. (GSK)
6.1.5.1 Company overview
6.1.5.2 Financial performance
6.1.5.3 Product benchmarking
6.1.6 Pfizer, Inc.
6.1.6.1 Company overview
6.1.6.2 Product benchmarking
6.1.7 Dong-A ST Co., Ltd.
6.1.7.1 Company overview
6.1.7.2 Financial performance
6.1.7.3 Product benchmarking
6.1.7.4 Strategic initiatives
6.1.8 Merck Sharp & Dohme Corp.
6.1.8.1 Company overview
6.1.8.2 Financial Performance
6.1.8.3 Product benchmarking
6.1.8.4 Strategic initiatives
6.1.9 Bayer HealthCare
6.1.9.1 Company overview
6.1.9.2 Financial Performance
6.1.9.3 Product benchmarking
6.1.9.4 Strategic initiatives
6.1.10 Arena Pharmaceuticals
6.1.10.1 Company overview
6.1.10.2 Financial performance
6.1.10.3 Product benchmarking
Chapter 7 KOL Commentary
7.1 Key Insights
7.2 KOL Views
Chapter 8 Recommendations

List of Tables

Table 1 List of abbreviation
Table 2 Vendor landscape, 2019
Table 3 Fire alarm and detection market, 2016 - 2027 (USD Million)
Table 4 Fire detectors market, 2016 - 2027 (USD Million)
Table 5 Fire alarms market, 2016 - 2027 (USD Million)
Table 6 Flame detectors market, 2016 - 2027 (USD Million)
Table 7 Smoke detectors market, 2016 - 2027 (USD Million)
Table 8 Heat detectors market, 2016 - 2027 (USD Million)
Table 9 Audible alarms market, 2016 - 2027 (USD Million)
Table 10 Visual alarms market, 2016 - 2027 (USD Million)
Table 11 Manual call-points market, 2016 - 2027 (USD Million)
Table 12 Commercial fire alarm and detection market, 2016 - 2027 (USD Million)
Table 13 Industrial fire alarm and detection market, 2016 - 2027 (USD Million)
Table 14 Residential fire alarm and detection market, 2016 - 2027 (USD Million)
Table 15 North America fire alarm and detection market, by country, 2016 - 2027 (USD Million)
Table 16 North America fire alarm and detection market, by product, 2016 - 2027 (USD Million)
Table 17 North America fire alarm and detection market, fire detectors by type, 2016 - 2027 (USD Million)
Table 18 North America fire alarm and detection market, fire alarms by type, 2016 - 2027 (USD Million)
Table 19 North America fire alarm and detection market, by application, 2016 - 2027 (USD Million)
Table 20 U.S. fire alarm and detection market, by product, 2016 - 2027 (USD Million)
Table 21 U.S. fire alarm and detection market, fire detectors by type, 2016 - 2027 (USD Million)
Table 22 U.S. fire alarm and detection market, fire alarms by type, 2016 - 2027 (USD Million)
Table 23 U.S. fire alarm and detection market, by application, 2016 - 2027 (USD Million)
Table 24 Canada fire alarm and detection market, by product, 2016 - 2027 (USD Million)
Table 25 Canada fire alarm and detection market, fire detectors by type, 2016 - 2027 (USD Million)
Table 26 Canada fire alarm and detection market, fire alarms by type, 2016 - 2027 (USD Million)
Table 27 Canada fire alarm and detection market, by application, 2016 - 2027 (USD Million)
Table 28 Europe fire alarm and detection market, by country, 2016 - 2027 (USD Million)
Table 29 Europe fire alarm and detection market, by product, 2016 - 2027 (USD Million)
Table 30 Europe fire alarm and detection market, fire detectors by type, 2016 - 2027 (USD Million)
Table 31 Europe fire alarm and detection market, fire alarms by type, 2016 - 2027 (USD Million)
Table 32 Europe fire alarm and detection market, by application, 2016 - 2027 (USD Million)
Table 33 Germany fire alarm and detection market, by product, 2016 - 2027 (USD Million)
Table 34 Germany fire alarm and detection market, fire detectors by type, 2016 - 2027 (USD Million)
Table 35 Germany fire alarm and detection market, fire alarms by type, 2016 - 2027 (USD Million)
Table 36 Germany fire alarm and detection market, by application, 2016 - 2027 (USD Million)
Table 37 U.K. fire alarm and detection market, by product, 2016 - 2027 (USD Million)
Table 38 U.K. fire alarm and detection market, fire detectors by type, 2016 - 2027 (USD Million)
Table 39 U.K. fire alarm and detection market, fire alarms by type, 2016 - 2027 (USD Million)
Table 40 U.K. fire alarm and detection market, by application, 2016 - 2027 (USD Million)
Table 41 Asia Pacific fire alarm and detection market, by country, 2016 - 2027 (USD Million)
Table 42 Asia Pacific fire alarm and detection market, by product, 2016 - 2027 (USD Million)
Table 43 Asia Pacific fire alarm and detection market, fire detectors by type, 2016 - 2027 (USD Million)
Table 44 Asia Pacific fire alarm and detection market, fire alarms by type, 2016 - 2027 (USD Million)
Table 45 Asia Pacific fire alarm and detection, by application, 2016 - 2027 (USD Million)
Table 46 China fire alarm and detection market, by product, 2016 - 2027 (USD Million)
Table 47 China fire alarm and detection market, fire detectors by type, 2016 - 2027 (USD Million)
Table 48 China fire alarm and detection market, fire alarms by type, 2016 - 2027 (USD Million)
Table 49 China fire alarm and detection market, by application, 2016 - 2027 (USD Million)
Table 50 Japan fire alarm and detection market, by product, 2016 - 2027 (USD Million)
Table 51 Japan fire alarm and detection, fire detectors by type, 2016 - 2027 (USD Million)
Table 52 Japan fire alarm and detection, fire alarms by type, 2016 - 2027 (USD Million)
Table 53 Japan fire alarm and detection, by application, 2016 - 2027 (USD Million)
Table 54 India fire alarm and detection market, by product, 2016 - 2027 (USD Million)
Table 55 India fire alarm and detection market, fire detectors by type, 2016 - 2027 (USD Million)
Table 56 India fire alarm and detection market, fire alarms by type, 2016 - 2027 (USD Million)
Table 57 India fire alarm and detection market, by application, 2016 - 2027 (USD Million)
Table 58 Latin America fire alarm and detection market, by country, 2016 - 2027 (USD Million)
Table 59 Latin America fire alarm and detection market, by product, 2016 - 2027 (USD Million)
Table 60 Latin America fire alarm and detection market, fire detectors by type, 2016 - 2027 (USD Million)
Table 61 Latin America fire alarm and detection market, fire alarms by type, 2016 - 2027 (USD Million)
Table 62 Latin America fire alarm and detection market, by application, 2016 - 2027 (USD Million)
Table 63 Brazil fire alarm and detection market, by product, 2016 - 2027 (USD Million)
Table 64 Brazil fire alarm and detection market, fire detectors by type, 2016 - 2027 (USD Million)
Table 65 Brazil fire alarm and detection market, fire alarms by type, 2016 - 2027 (USD Million)
Table 66 Brazil fire alarm and detection market, by application, 2016 - 2027 (USD Million)
Table 67 Mexico fire alarm and detection market, by product, 2016 - 2027 (USD Million)
Table 68 Mexico fire alarm and detection market, fire detectors by type, 2016 - 2027 (USD Million)
Table 69 Mexico fire alarm and detection market, fire alarms by type, 2016 - 2027 (USD Million)
Table 70 Mexico fire alarm and detection market, by application, 2016 - 2027 (USD Million)
Table 71 MEA fire alarm and detection market, by product, 2016 - 2027 (USD Million)
Table 72 MEA fire alarm and detection market, fire detectors by type, 2016 - 2027 (USD Million)
Table 73 MEA fire alarm and detection market, fire alarms by type, 2016 - 2027 (USD Million)
Table 74 MEA fire alarm and detection market, by application, 2016 - 2027 (USD Million)


List of Figures

Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Fire alarm and detection market segmentation
Fig. 4 Fire alarm and detection market snapshot
Fig. 5 Fire alarm and detection market, 2016 - 2027 (USD Million)
Fig. 6 Fire alarm and detection market, by product, 2016 - 2027 (USD Million)
Fig. 7 Fire alarm and detection market, fire detectors by type, 2016 - 2027 (USD Million)
Fig. 8 Fire alarm and detection market, fire alarms by type, 2016 - 2027 (USD Million)
Fig. 9 Fire alarm and detection market, by application, 2016 - 2027 (USD Million)
Fig. 10 Fire alarm and detection market, by region, 2016 - 2027 (USD Million)
Fig. 11 Fire alarm and detection market: Value chain analysis
Fig. 12 Fire alarm and detection market penetration and growth prospect mapping
Fig. 13 Fire alarm and detection market : Key company analysis, 2019
Fig. 14 Fire alarm and detection market: PEST analysis
Fig. 15 Fire alarm and detection market: PORTER’s analysis
Fig. 16 Fire alarm and detection market: Product analysis
Fig. 17 Fire alarm and detection market: Fire detectors by type analysis
Fig. 18 Fire alarm and detection market: Fire alarms by type analysis
Fig. 19 Fire alarm and detection market: Application analysis
Fig. 20 Fire alarm and detection market: Regional analysis
Fig. 21 North America fire alarm and detection market - key takeaways
Fig. 22 Europe fire alarm and detection market - key takeaways
Fig. 23 Asia Pacific fire alarm and detection market - key takeaways
Fig. 24 Latin America fire alarm and detection market - key takeaways
Fig. 25 MEA fire alarm and detection market - key takeaways

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[肺動脈高血圧の世界市場:薬物クラス別(プロスタサイクリン&プロスタサイクリン類似体、ERA、PDE-5)]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆